Rigel Pharmaceuticals Inc (NAS:RIGL)
$ 16.5 -0.76 (-4.4%) Market Cap: 304.04 Mil Enterprise Value: 303.15 Mil PE Ratio: 75.04 PB Ratio: 0 GF Score: 77/100

Rigel Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 27, 2023 / 07:35PM GMT
Release Date Price: $11.1 (-2.63%)
Unidentified Analyst

Hi. Good afternoon, everyone. Welcome to the Cantor Conference. I wanted to introduce Dean Schorno, who's the CFO of Rigel. Thanks so much for being at our conference.

Dean L. Schorno
Rigel Pharmaceuticals, Inc. - Executive VP & CFO

Well, thanks, Kristen, for having us and the entire Cantor team for inviting us to your conference. And thanks to all of you for being here today and showing your interest in Rigel.

So as I get started today, I'll be making some forward-looking statements. And just to remind you, I encourage you to take a look at our investor site at rigel.com, for more detail about the company, our corporate presentation deck as well as our SEC filings for more detail.

So I'm really excited today to be here to talk about our hematology oncology-focused business. It's really an exciting time for Rigel. And there's a variety of ways that we look to grow the business, and it's exciting times to grow the business.

Today, I'll talk about a couple of paths forward with respect to that growth. Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot